What does Scinai Immunotherapeutics Ltd. do?

Scinai Immunotherapeutics Ltd. is a public company in the Biological Products, (No Diagnostic Substances) industry, incorporated in L3. It is registered with the SEC under CIK 0001611747 and trades on NASDAQ under the ticker SCNI.

Is Scinai Immunotherapeutics Ltd. profitable?

Scinai Immunotherapeutics Ltd. reported a net loss of $5.80M in FY2022. This figure is sourced from its SEC EDGAR 10-K annual report.

How many SEC filings has Scinai Immunotherapeutics Ltd. made?

Scinai Immunotherapeutics Ltd. has filed 466 documents with the SEC since 2014. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Scinai Immunotherapeutics Ltd.

SCNI NASDAQ CIK: 0001611747 Biological Products, (No Diagnostic Substances) Inc. in L3

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 466 filings →

Form	Description	Date
3	FORM 3	Mar 26, 2026
6-K	REPORT OF FOREIGN PRIVATE ISSUER	Mar 23, 2026
6-K	REPORT OF FOREIGN PRIVATE ISSUER	Mar 19, 2026
3	FORM 3	Mar 18, 2026
3	—	Mar 18, 2026
3	FORM 3	Mar 18, 2026
3	FORM 3	Mar 18, 2026
3	—	Mar 18, 2026
3	FORM 3	Mar 18, 2026
3	FORM 3	Mar 18, 2026

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Scinai Immunotherapeutics Ltd.. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Net Income: ($5.80M) (FY2022)
Total Assets: $27.07M (FY2022)
Operating Income: ($11.06M)

Full financials →

Details

CIK: 0001611747
Ticker: SCNI
Exchange: NASDAQ
Incorporated: L3
First Filing: 2014
Total Filings: 466

Biological Products, (No Diagnostic Substances) rankings →